Phosphodiesterase
Products Related to Phosphodiesterase(34)
- GC48243Vardenafil-d5CAS: 1189685-70-8Purity: >99.00%
An internal standard for the quantification of vardenafil
- GC48469Moexipril-d5CAS: 1356929-49-1Purity: >99.00%
An internal standard for the quantification of moexipril
- GC48856Fenspiride-d5CAS: 1246911-67-0Purity: >99.00%
An internal standard for the quantification of fenspiride
- GC49683N-desethyl-N-methyl VardenafilCAS: 224785-87-9Purity: >95.00%
A potential impurity found in commercial preparations of vardenafil
- GC62215CRT0273750CAS: 1979939-16-6Purity: >98.50%
CRT0273750은 오토탁신(ATX) 억제제이며 혈장 내 LPA 수준을 조절합니다(IC50 = 0.014μM). CRT0273750은 ATX/LPA 의존 암 모델에 사용할 수 있습니다.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC48243 | Vardenafil-d5 | 1189685-70-8 | >99.00% | |
An internal standard for the quantification of vardenafil | ||||
| GC48469 | Moexipril-d5 | 1356929-49-1 | >99.00% | |
An internal standard for the quantification of moexipril | ||||
| GC48856 | Fenspiride-d5 | 1246911-67-0 | >99.00% | |
An internal standard for the quantification of fenspiride | ||||
| GC48870 | Anagrelide-13C3 | - | >98.00% | |
| GC49079 | C82 | 691862-35-8 | >98.00% | |
An Mtb CdnP inhibitor | ||||
| GC49186 | O-Demethyl Apremilast | 1384441-38-6 | >95.00% | |
An active metabolite of apremilast | ||||
| GC49349 | O-Desethyl Sildenafil | 139755-91-2 | >95.00% | |
A metabolite of sildenafil | ||||
| GC49683 | N-desethyl-N-methyl Vardenafil | 224785-87-9 | >95.00% | |
A potential impurity found in commercial preparations of vardenafil | ||||
| GC60886 | GSK356278 | 720704-34-7 | >99.50% | |
GSK356278은 인간 PDE4A, PDE4B 및 PDE4D에 대해 각각 8.6, 8.8 및 8.7의 pIC50을 갖는 포스포디에스테라제 4(PDE4)의 강력하고 선택적인 경구 생체이용 및 뇌 침투 억제제입니다. | ||||
| GC62215 | CRT0273750 | 1979939-16-6 | >98.50% | |
CRT0273750은 오토탁신(ATX) 억제제이며 혈장 내 LPA 수준을 조절합니다(IC50 = 0.014μM). CRT0273750은 ATX/LPA 의존 암 모델에 사용할 수 있습니다. | ||||
